NYSE Content Update: Defense Tech Company AEVEX to Make Its Public Debut
The NYSE daily pre-market update announced that defense tech company AEVEX (NYSE: AVEX) will make its public debut on April 17, 2026, with CEO Roger Wells joining NYSE Live. The update also noted Madison Air's (NYSE: MAIR) significant first-day pop and presidential comments impacting the markets. Pinnacle West Capital (NYSE: PNW) is celebrating its 65th anniversary of listing.
Equinix opens SP6 data center in São Paulo, Brazil
Equinix has launched its new SP6 data center in São Paulo, Brazil, with an investment of $114 million. This facility adds to their existing nine data centers in Brazil and is designed for liquid cooling and AI readiness. Equinix plans further expansion with future SP7 and additional data centers at the same complex.
Rockefeller Nabs Billion-Dollar Morgan Stanley Duo in Oklahoma
Rockefeller Global Family Office successfully recruited a Morgan Stanley team, Red Rock Private Wealth Partners, in Oklahoma City. The team, led by advisors Ian M. Ogilvie and Kevin R. Kurtz, managed $1 billion in assets and generated $6.5 million in annual revenue. This move follows Rockefeller's recent reorganization and recapitalization, demonstrating its growth strategy through recruiting veteran brokers.
What to Expect From Bio-Techne's Q3 2026 Earnings Report
Bio-Techne Corporation (TECH) is expected to report its Q3 2026 earnings on May 6, with analysts forecasting a 4% decrease in EPS to $0.48 compared to the previous year. Despite underperforming the S&P 500, TECH has outperformed the healthcare sector ETF. The company faces challenges with no organic revenue growth in the last two years and a decrease in free cash flow margin, leading analysts to rate it as a "Moderate Buy" with a target upside of 21.2%.
Rep. Jennifer McClellan Has Sold Up to $250K Worth Of Verizon Communications Stock: Here's What You Should Know
Representative Jennifer McClellan recently sold between $100,001 and $250,000 worth of Verizon Communications stock on April 7, 2026, as detailed in an April 16, 2026 official report. This transaction, along with others by government officials, is publicly disclosed under the STOCK Act to ensure transparency and prevent the use of private information for personal gain. Congressional transactions can serve as a factor for investors to consider, although they should not be the sole basis for investment decisions.
Watch CNBC's full interview with KeyCorp CEO Chris Gorman
KeyCorp CEO Chris Gorman was interviewed on 'Squawk on the Street' to discuss the company's recent earnings report. He also addressed concerns related to private credit during the extensive discussion. The full interview provides insights into KeyCorp's financial performance and broader market topics.
Diodes Incorporated stock hits 52-week high at 96.49 USD By Investing.com
Diodes Incorporated (NASDAQ:DIOD) stock reached a new 52-week high of $96.49, reflecting a 174% one-year return and a 90% year-to-date return. Despite this achievement, InvestingPro suggests the stock might be overvalued. The company recently reported mixed Q4 2025 earnings, with an EPS miss but revenue beat. Analysts have upgraded Diodes' stock rating and increased price targets due to a positive cyclical recovery outlook and expanded product offerings.
IT UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gartner (IT) Investors of Securities Class Action Deadline on May 18, 2026
Faruqi & Faruqi, LLP is investigating potential securities claims against Gartner, Inc. (NYSE: IT) and reminding investors of a May 18, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges that Gartner made false and misleading statements about its growth rates and ability to meet consulting revenue targets, causing investors to purchase securities at inflated prices. This follows a significant drop in Gartner's stock price on February 3, 2026, after the company reported lower-than-expected 2026 financial forecasts.
OpenAI Launches GPT-Rosalind AI Model Tailored for Drug Discovery and Biology Research
OpenAI has introduced GPT-Rosalind, a specialized AI model developed for early-stage drug discovery and life sciences research, covering areas like biochemistry, genomics, and protein engineering. This model integrates with over 50 scientific databases and is initially accessible through a vetted US enterprise program with partners including Amgen, Moderna, and Thermo Fisher Scientific. GPT-Rosalind has demonstrated superior performance on various scientific benchmarks, surpassing human experts in RNA prediction tasks and outperforming other AI models in research tasks like protocol design.
From $58 to $35: Chipotle Mexican Grill Stock at Its Lowest Multiple in Years
Chipotle Mexican Grill (CMG) stock has fallen significantly and is trading at multi-year lows, driven by declining comparable restaurant sales and major institutional investor exits. Despite these challenges, the company is implementing a recovery strategy focused on high-efficiency kitchen equipment and menu innovation, which has shown early positive results in equipped locations. Analysts anticipate a recovery, with a mean price target of $44 and a TIKR model target of $70 by 2030, suggesting the stock is currently undervalued given its operational catalysts.


